Literature DB >> 9855303

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats.

A Fink-Jensen1, P Kristensen, H E Shannon, D O Calligaro, N W Delapp, C Whitesitt, J S Ward, C Thomsen, T Rasmusseen, M J Sheardown, L Jeppesen, P Sauerberg, F P Bymaster.   

Abstract

(5R,6R) 6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]oc tane (PTAC) is a selective muscarinic ligand with high affinity for central muscarinic receptors, agonist mode of action at the muscarinic M2 and M4 receptor subtypes and substantially less or no affinity for central dopamine receptors. In the present study PTAC, as well as the muscarinic agonists oxotremorine, RS86 and pilocarpine, inhibited dopamine D1 and D2 receptor agonist induced contralateral rotation in unilaterally 6-OHDA lesioned rats. The dose of SKF 38393 used to induce contralateral rotation also caused an intense Fos protein immunoreactivity in the rat dorsolateral striatum on the lesioned site which was inhibited by PTAC indicating that the inhibition of rotation by PTAC was not due to non-specific peripheral side effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855303     DOI: 10.1097/00001756-199810260-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  2 in total

1.  Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.

Authors:  Morgane Thomsen; Jürgen Wess; Brian S Fulton; Anders Fink-Jensen; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

2.  Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission.

Authors:  Miguel Garzón; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2013-09-01       Impact factor: 3.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.